← Back to headlines
AstraZeneca's $400 Billion Deal Unravels Amid Investor Revolt
A potential $400 billion deal involving AstraZeneca reportedly fell apart after a significant number of investors expressed strong opposition.
12 Aug, 04:00 — 12 Aug, 04:00
Sources
Showing 1 of 1 sources
Related Stories
Uber and Wayve Launch London’s First Autonomous Robotaxi Service
18m ago
Berkshire Hathaway Signals Intent to Increase Stakes in Japanese Trading Houses
40m ago
Rising US-Iran Military Tensions Spark Regional War Fears and Oil Volatility
45m ago
Diversified Energy to Acquire Elliott-Backed Birch Energy for $1.8 Billion
56m ago